Financial Statements — IPX
Balance Sheet
(in millions USD)| Metric | Q2
2026 |
|---|
| Cash & Equivalents | 65.83 |
| Inventory | 0.43 |
| Total Current Assets | 69.57 |
| Total Non-current Assets | 59.58 |
| Total Assets | 129.16 |
| Total Current Liabilities | 17.27 |
| Total Non-current Liabilities | 3.69 |
| Total Liabilities | 20.95 |
| Retained Earnings | (144.00) |
| Total Stockholder Equity | 108.20 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 |
|---|
| Research & Development | 10.79 |
| Selling, General & Admin | 16.21 |
| Pretax Income | (34.77) |
| Tax Provision | 0.00 |
| Net Income | (34.77) |
| Basic EPS | (0.10) |
| Diluted EPS | (0.10) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 |
|---|
| Operating Cash Flow | (16.70) |
| Investing Cash Flow | (16.38) |
| Financing Cash Flow | 43.92 |